Xenetic Biosciences, Inc. (XBIO)
1.72
-0.21
(-10.88%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
-0.01
(-0.58%)
After-Hours: 20:00
Xenetic Biosciences Market Cap : 4.030M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.030M |
| October 22, 2026 | 4.522M |
| October 21, 2026 | 4.733M |
| October 20, 2026 | 4.686M |
| October 19, 2026 | 4.522M |
| October 16, 2026 | 4.663M |
| October 15, 2026 | 4.710M |
| October 14, 2026 | 4.921M |
| October 13, 2026 | 4.921M |
| October 12, 2026 | 4.968M |
| October 09, 2026 | 4.991M |
| October 08, 2026 | 4.968M |
| October 07, 2026 | 5.178M |
| October 06, 2026 | 4.968M |
| October 05, 2026 | 5.155M |
| October 02, 2026 | 5.249M |
| October 01, 2026 | 5.249M |
| September 30, 2026 | 5.436M |
| September 29, 2026 | 5.296M |
| September 28, 2026 | 5.460M |
| September 25, 2026 | 5.600M |
| September 24, 2026 | 5.788M |
| September 23, 2026 | 5.905M |
| September 22, 2026 | 6.022M |
| September 21, 2026 | 7.006M |
| Date | Value |
|---|---|
| September 18, 2026 | 6.491M |
| September 17, 2026 | 5.764M |
| September 16, 2026 | 5.132M |
| September 15, 2026 | 10.01M |
| September 14, 2026 | 10.15M |
| September 11, 2026 | 9.138M |
| September 10, 2026 | 9.537M |
| September 09, 2026 | 9.877M |
| September 08, 2026 | 10.03M |
| September 04, 2026 | 10.94M |
| September 03, 2026 | 10.85M |
| September 02, 2026 | 9.959M |
| September 01, 2026 | 9.912M |
| August 31, 2026 | 9.818M |
| August 28, 2026 | 9.326M |
| August 27, 2026 | 9.302M |
| August 26, 2026 | 9.045M |
| August 25, 2026 | 8.951M |
| August 24, 2026 | 8.928M |
| August 21, 2026 | 8.412M |
| August 20, 2026 | 7.943M |
| August 19, 2026 | 7.873M |
| August 18, 2026 | 7.615M |
| August 17, 2026 | 7.639M |
| August 14, 2026 | 7.686M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 1.110 |
| Price to Book Value | 0.6636 |
| Price | 1.72 |
| Earnings Yield | -69.06% |